PCM
ZBH icon

Palouse Capital Management’s Zimmer Biomet ZBH Stock Holding History

Palouse Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40
Closed -$5.28K – 155
2024
Q1 		$5.28K Buy
+40
New +$5K ﹤0.01% 138
2019
Q3 		– Sell
-16,595
Closed -$1.9M – 109
2019
Q2 		$1.9M Sell
16,595
-919
-5% -$108K 0.68% 48
2019
Q1 		$2.17M Sell
17,514
-1,425
-8% -$162K 0.83% 47
2018
Q4 		$1.91M Sell
18,939
-117
-0.6% -$13.2K 0.75% 50
2018
Q3 		$2.43M Sell
19,056
-170
-0.9% -$20.2K 0.85% 45
2018
Q2 		$2.08M Sell
19,226
-306
-2% -$33.3K 0.7% 53
2018
Q1 		$2.07M Sell
19,532
-153
-0.8% -$17.8K 0.69% 55
2017
Q4 		$2.31M Sell
19,685
-235
-1% -$26.6K 0.78% 50
2017
Q3 		$2.27M Buy
19,920
+172
+0.9% +$19.9K 0.76% 53
2017
Q2 		$2.46M Sell
19,748
-369
-2% -$43.7K 0.9% 47
2017
Q1 		$2.38M Sell
20,117
-130
-0.6% -$14.7K 0.91% 46
2016
Q4 		$2.03M Buy
+20,247
New +$2.17M 0.83% 51

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Palouse Capital Management's ZBH Position: Q2 2024 in Review

Palouse Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 40 shares — an estimated $5.28K sold.

Palouse Capital Management first reported a position in ZBH in Q4 2016 and held it in 12 quarters. The position peaked at $2.46M in Q2 2017. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Palouse Capital Management reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Palouse Capital Management sold 40 Zimmer Biomet shares in Q2 2024, an estimated $5.28K.
  • Palouse Capital Management first reported a position in Zimmer Biomet in Q4 2016 and held it in 12 quarters.
  • Palouse Capital Management's Zimmer Biomet position peaked at $2.46M in Q2 2017.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Palouse Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.